Zahed Subhan
Directeur Général chez Marillion Pharmaceuticals, Inc.
Profil
Zahed Subhan is the founder of Marillion Pharmaceuticals, Inc. He previously worked as the Chief Executive Officer of Nuevolution AB, Vice President-Business Development at Locus Pharmaceuticals, Inc., Chief Business Officer at Melior Discovery, Inc., Chief Business Officer at Gemini Genomics Plc, Director at Arbovax, Inc., and Advisor at HealthPro BioVentures LLC.
He holds an MBA from the University of Bradford, an undergraduate degree from the University of Sunderland, a doctorate from the University of Leeds, and graduate degrees from the University of Aston and the University of West London.
Postes actifs de Zahed Subhan
| Sociétés | Poste | Début |
|---|---|---|
Marillion Pharmaceuticals, Inc.
 Marillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Marillion Pharmaceuticals, Inc. provides cancer pharmaceuticals. It focuses on the development and commercialization of novel therapeutics for the treatment of cancers and for care in oncology. The firm products include Lu-AMBA, Pilobuc, and MN-201. The company was founded by Jerry Glickson, Zahed Subhan, and Gang Zheng in February 2005 and is headquartered in Radnor, PA. | Directeur Général | - |
Anciens postes connus de Zahed Subhan
| Sociétés | Poste | Fin |
|---|---|---|
| ADHERA THERAPEUTICS, INC. | Directeur Général | 12/01/2024 |
Melior Discovery, Inc.
 Melior Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Melior Discovery, Inc. provides phenotypic screening, in vivo pharmacology, drug abuse liability and seizure potential services. It offers theraTRACE, an indications discovery platform of multiplexed in vivo models that focus on various indications/therapeutic areas, including neurodegenerative disease and psychiatry, inflammation, acute and chronic pain, metabolic disease, gastrointestinal & urology, cardiovascular disease, and dermatology aspects. The company was founded by Andrew G. Reaume and Michael S. Saporito in 2005 and is headquartered in Exton, PA. | Corporate Officer/Principal | 01/08/2011 |
Arbovax, Inc.
 Arbovax, Inc. Pharmaceuticals: MajorHealth Technology Arbovax, Inc. engages in the research and development of vaccines against arthropod-borne diseases. The firm facilitates development of vaccines against insect-borne viruses and focuses on dengue fever, chikungunya fever, west Nile virus, and veterinary markets. The company was founded by Malcolm E. Thomas, Jonathan Lawrie, Brown T. Dennis and Raquel Hernandez in October 2005 and is headquartered in Raleigh, NC. | Directeur/Membre du Conseil | - |
| NUEVOLUTION AB (PUBL) | Directeur Général | - |
Locus Pharmaceuticals, Inc.
 Locus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Locus Pharmaceuticals is a pharmaceutical company focused on developing novel, small molecule therapeutics to address major unmet medical needs. Locus utilizes powerful and proprietary computational technologies running on Linux-based supercomputer clusters to simultaneously identify relevant binding sites on protein disease targets and rapidly generate novel, small molecules that bind specifically to those protein sites. In contrast to other computational approaches, the Locus technology requires only a high-resolution, 3-dimensional structure of the target protein to implement its drug discovery process. Locus Pharmaceuticals is synthesizing and testing novel drug candidates for the treatment of debilitating and life-threatening human diseases, including HIV/AIDS, cancer, arthritis and inflammation. | Corporate Officer/Principal | - |
Formation de Zahed Subhan
| University of Bradford | Masters Business Admin |
| University of Sunderland | Undergraduate Degree |
| University of Leeds | Doctorate Degree |
| University of Aston | Graduate Degree |
| University of West London | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ADHERA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 7 |
|---|---|
Gemini Genomics Plc
 Gemini Genomics Plc Miscellaneous Commercial ServicesCommercial Services Part of Laboratory Corp. of America Holdings, Gemini Genomics Plc is a British company that provides clinical genomics services. The company is based in Cambridge, UK. The company was founded by Michael Edward Fitzgerald, Paul James Kelly. | Commercial Services |
Melior Discovery, Inc.
Melior Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Melior Discovery, Inc. provides phenotypic screening, in vivo pharmacology, drug abuse liability and seizure potential services. It offers theraTRACE, an indications discovery platform of multiplexed in vivo models that focus on various indications/therapeutic areas, including neurodegenerative disease and psychiatry, inflammation, acute and chronic pain, metabolic disease, gastrointestinal & urology, cardiovascular disease, and dermatology aspects. The company was founded by Andrew G. Reaume and Michael S. Saporito in 2005 and is headquartered in Exton, PA. | Commercial Services |
Locus Pharmaceuticals, Inc.
Locus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Locus Pharmaceuticals is a pharmaceutical company focused on developing novel, small molecule therapeutics to address major unmet medical needs. Locus utilizes powerful and proprietary computational technologies running on Linux-based supercomputer clusters to simultaneously identify relevant binding sites on protein disease targets and rapidly generate novel, small molecules that bind specifically to those protein sites. In contrast to other computational approaches, the Locus technology requires only a high-resolution, 3-dimensional structure of the target protein to implement its drug discovery process. Locus Pharmaceuticals is synthesizing and testing novel drug candidates for the treatment of debilitating and life-threatening human diseases, including HIV/AIDS, cancer, arthritis and inflammation. | Health Technology |
HealthPro BioVentures LLC
 HealthPro BioVentures LLC Investment ManagersFinance Founded in 2003, HealthPro BioVentures LLC is a life sciences investment bank and strategic advisory firm headquartered in New York City | Finance |
Nuevolution AB
 Nuevolution AB Pharmaceuticals: MajorHealth Technology Nuevolution AB engages in pharmaceutical and biotechnology discovery. Its activities include research and development, and licensing drugs and treatment of oncology and chronic inflammatory diseases including cancer. It offers the platform Chemetics, which enables discovery of small molecule drug candidates for specific indications addressing target diseases. The company was founded by Henrik Pedersen, Alex Haahr Gouliaev, and Mads Nørregaard-Madsen in May 2001 and is headquartered in Copenhagen, Denmark. | Health Technology |
Arbovax, Inc.
Arbovax, Inc. Pharmaceuticals: MajorHealth Technology Arbovax, Inc. engages in the research and development of vaccines against arthropod-borne diseases. The firm facilitates development of vaccines against insect-borne viruses and focuses on dengue fever, chikungunya fever, west Nile virus, and veterinary markets. The company was founded by Malcolm E. Thomas, Jonathan Lawrie, Brown T. Dennis and Raquel Hernandez in October 2005 and is headquartered in Raleigh, NC. | Health Technology |
Marillion Pharmaceuticals, Inc.
Marillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Marillion Pharmaceuticals, Inc. provides cancer pharmaceuticals. It focuses on the development and commercialization of novel therapeutics for the treatment of cancers and for care in oncology. The firm products include Lu-AMBA, Pilobuc, and MN-201. The company was founded by Jerry Glickson, Zahed Subhan, and Gang Zheng in February 2005 and is headquartered in Radnor, PA. | Health Technology |
